Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial
PaperCitations, authors & open-access status
2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 1,514 citations, 2007 year and closed oa status.
1,514
Citations
2007
Year
closed
OA Status